Switzerland's news in English

Editions:  Europe · Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland

Richemont profits up on China revenue

Share this article

10:59 CET+01:00

Swiss luxury group Richemont said on Friday that it expects to post "significantly higher" operating profits in 2011, as strong demand in China appeared to defy the current gloomy global economic climate.

Sales for the six months ending September 30th jumped 29 percent to €4.21 billion ($5.75 billion), while net profit for the period was up 10 percent at €709 million.

Sales in the Asia-Pacific region soared 48 percent to 1.71 billion francs ($1.88 billion), "primarily driven by mainland China, which is now Richemont's third largest market after Hong Kong and the US."

Despite a debt crisis, European markets also returned sales growth of 20 percent to €1.51 billion. However, demand came not from the continent itself, but from travellers, as well as Russia, noted Richemont, which owns brands such as Cartier and Piaget.

Johann Rupert, chairman and chief executive of the group described the earnings as "solid" and issued a positive forecast for the rest of the financial year.

For the second half of the financial year, we face both the impact of global economic problems on the luxury goods industry in general, and the demanding comparative figures against which group sales will be measured," he acknowledged.

"Notwithstanding these challenges and based on the group's performance for the year to date, operating profit for the full year is expected to be significantly higher than last year," he said.

Get notified about breaking news on The Local

Share this article

The Local is not responsible for content posted by users.
Become a Member or sign-in to leave a comment.

From our sponsors

VIDEO: Three surprising facts that will make you want to visit Malta

Game of Thrones has ended but it lives on in Malta! Find out how and learn two more unexpected facts about this little archipelago in the middle of the Med.